Push to recognise early combo therapy in type 2 diabetes

GPs are divided over whether Australian guidelines should support combination therapy in new-onset type 2 diabetes with high HbA1c, as supported by international guidelines.   

Two presentations at the European Society for the Study of Diabetes conference last week have highlighted the efficacy of early combination therapy in patients with new-onset type 2 disease.

Professor Jochen